Roche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trialRoche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trial - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 14, 2023 at 1:30 PM in business No comments 26